These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 7776110

  • 1. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
    Corbet A, Gerdes J, Long W, Avila E, Puri A, Rosenberg A, Edwards K, Cook L.
    J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
    [Abstract] [Full Text] [Related]

  • 2. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W, Thompson T, Sundell H, Schumacher R, Volberg F, Guthrie R.
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [Abstract] [Full Text] [Related]

  • 3. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
    Stevenson D, Walther F, Long W, Sell M, Pauly T, Gong A, Easa D, Pramanik A, LeBlanc M, Anday E.
    J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
    [Abstract] [Full Text] [Related]

  • 4. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
    Smyth J, Allen A, MacMurray B, Peliowski A, Sankaran K, Volberg F, Shukla A, Long W.
    J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
    [Abstract] [Full Text] [Related]

  • 5. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V.
    N Engl J Med; 1991 Dec 12; 325(24):1696-703. PubMed ID: 1944470
    [Abstract] [Full Text] [Related]

  • 6. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
    Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W.
    J Pediatr; 1991 Feb 12; 118(2):277-84. PubMed ID: 1993961
    [Abstract] [Full Text] [Related]

  • 7. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
    Bose C, Corbet A, Bose G, Garcia-Prats J, Lombardy L, Wold D, Donlon D, Long W.
    J Pediatr; 1990 Dec 12; 117(6):947-53. PubMed ID: 2246698
    [Abstract] [Full Text] [Related]

  • 8. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cummings NJ, Jung AL, Kimberlin LV, Auten RL, Rosenberg AA, Asselin JM, Belcastro MR, Donohue PK, Hamm CR, Jansen RD, Brody AS, Riddlesberger MM, Montgomery P.
    Pediatrics; 1997 Jul 12; 100(1):39-50. PubMed ID: 9200358
    [Abstract] [Full Text] [Related]

  • 9. One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.
    Walther FJ, Mullett M, Schumacher R, Sundell H, Easa D, Long W.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S13-9. PubMed ID: 7745506
    [Abstract] [Full Text] [Related]

  • 10. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
    Corbet AJ, Long WA, Murphy DJ, Garcia-Prats JA, Lombardy LR, Wold DE.
    J Paediatr Child Health; 1991 Aug 12; 27(4):245-9. PubMed ID: 1958425
    [Abstract] [Full Text] [Related]

  • 11. One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group.
    Saigal S, Robertson C, Sankaran K, Bingham W, Casiro O, MacMurray B, Whitfield M, Long W.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S61-7. PubMed ID: 7745513
    [Abstract] [Full Text] [Related]

  • 12. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
    McMillan D, Chernick V, Finer N, Schiff D, Bard H, Watts J, Krzeski R, Long W.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S90-8. PubMed ID: 7745517
    [Abstract] [Full Text] [Related]

  • 13. Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. American Exosurf Neonatal Study Groups I and II.
    Gerdes J, Gerdes M, Beaumont E, Cook L, Dhanireddy R, Kopleman A, Jarret R, Long W.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S26-32. PubMed ID: 7745508
    [Abstract] [Full Text] [Related]

  • 14. Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
    Sauve R, Long W, Vincer M, Bard H, Derleth D, Stevenson D, Pauly T, Robertson C.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S75-80. PubMed ID: 7745515
    [Abstract] [Full Text] [Related]

  • 15. One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    Gong A, Anday E, Boros S, Bucciarelli R, Burchfield D, Zucker J, Long W.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S68-74. PubMed ID: 7745514
    [Abstract] [Full Text] [Related]

  • 16. One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. Canadian Exosurf Neonatal Follow-Up Group.
    Casiro O, Bingham W, MacMurray B, Whitfield M, Saigal S, Vincer M, Long W.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S53-60. PubMed ID: 7745512
    [Abstract] [Full Text] [Related]

  • 17. Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
    Courtney SE, Long W, McMillan D, Walter D, Thompson T, Sauve R, Conway B, Bard H.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S43-52. PubMed ID: 7745510
    [Abstract] [Full Text] [Related]

  • 18. Double-blind evaluation of developmental and health status to age 2 years of infants weighing 700 to 1350 grams treated prophylactically at birth with a single dose of synthetic surfactant or air placebo.
    Kraybill EN, Bose CL, Corbet AJ, Garcia-Prats J, Asbill D, Edwards K, Long W.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S33-42. PubMed ID: 7745509
    [Abstract] [Full Text] [Related]

  • 19. One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    Sell M, Cotton R, Hirata T, Guthrie R, LeBlanc M, Mammel M, Long W.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S20-5. PubMed ID: 7745507
    [Abstract] [Full Text] [Related]

  • 20. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
    Online J Curr Clin Trials; 1992 Nov 10; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.